Table 2.
Lab | Extraction method |
Volume plasma (µl) |
Assay # |
Target | Assay type |
Quant/ Nested |
Primer Reference |
---|---|---|---|---|---|---|---|
CDC | Ultracentrifuge/ QIAamp viral RNA mini |
500 | 1 | pro | qRT-PCR | Quant | 15 |
2 | gag | RT-PCR southern |
Nested | 9 | |||
FDA (H) | Qiagen viral RNA mini |
140 | 1 | gag | RT-PCR | Nested | 2 |
FDA (Lo) | Ultracentrifuge/ TRIzol |
250 | 1 | gag | RT-PCR | Nested | 4 |
2 | gag | RT-PCR | Nested | 4 | |||
GP | Magnetic- based target capture |
500 | Duplex | Proprietary | TMA | N/A | Unpublished |
NCI | Ultracentrifuge including internal standard Guanidinium Isothicyanate |
~200– 500ul plasma |
1 | 5’ UTR of gag |
RT-PCR SCA |
Quant | Unpublished |
WPI | QIAamp viral RNA mini |
140 | 1 | 5’ UTR of gag |
qRT-PCR | Quant | 24 |